Precision BioSciences, Inc. Profile Avatar - Palmy Investing

Precision BioSciences, Inc.

Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides…

Biotechnology
US, Durham [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of DTIL's Analysis
CIK: 1357874 CUSIP: 74019P108 ISIN: US74019P2074 LEI: - UEI: -
Secondary Listings
DTIL has no secondary listings inside our databases.